The villagers gather in Pampa Hermoza.
The villagers of Pampa Hermoza, Peru, gathered in the wooden bleachers on the local football field, their faces turned toward the sky and their legs dangling freely over the ground below.
On this late December afternoon, they hoped to witness the first cargo drone delivery of antivenom to their remote settlement in the Amazonian rainforest. At first they were excited, but as time passed and the drone didn't show, they grew anxious.
Even more frustrated was Patrick Meier, executive director and co-founder of WeRobotics, a global nonprofit employing drones and robotics for humanitarian causes. Meier worked for months with the Peruvian government, his own local Flying Labs team, Peru's aviation authority and a US drone startup to get this test up and running.
Getting the project to work could be a lifesaver. Local doctors in the region report up to 45 snake bites, many of which are life threatening, every month among thousands of indigenous communities. Delivering the right antivenom can take hours by boat and foot, which is why WeRobotics and the Peruvian Health Ministry were keen to find out if cargo drones could realistically complete the task in a fraction of the time.
It's yet another potential application for drones, which have gone from being military tools to Lady Gaga 's backdrop at the Super Bowl. In Japan, researchers are developing drones that pollinate flowers, augmenting a declining bee population.
Drones are everywhere, cheap enough for you to buy on Amazon for your kid, and smart enough that retailers like Amazon are testing them for deliveries. The drone market is expected to nearly double to $11.2 billion by 2020, according to Gartner.
Beyond antivenom, WeRobotics has research teams in Peru, Tanzania and Nepal to explore other uses for drones, including combating the spread of the Zika virus.
Some drones are already providing health care in remote regions, especially for disaster relief scenarios, according to Stelios Kotakis, an analyst from IHS Markit. The growth will largely depend on the outcome of projects currently in the "experimental stage," he said.
For WeRobotics, its field test in Peru can be chalked up as a success -- albeit in a slightly roundabout way.
Just as Meier began to lose hope, the villagers started calling his name. A speck appeared on the horizon. The drone finally arrived -- five minutes later than expected. The flight took 35 minutes.
Children clapped and cheered as it swooped in and skidded smoothly across the grass. "There's video of me jumping up and down a dozen times and yelling hooray, hooray, hooray," Meier said.
He had good reason to be relieved.
The few days prior were rife with frustrations as the original $40,000 vertical takeoff and landing drone that arrived from North America failed to complete even one of the many dozens of planned flights.
Fortunately, there was a plan B.
Franky may not be pretty, but at least it can fly.
The team happened to bring an old $3,000 mapping drone along for the ride to the home base of Contamana, a six-hour riverboat journey from Pampa Hermoza. Battered, bruised and covered in gaffer tape, the mapping small fixed-wing drone, an Event 38 E384, was in such a state that Meier's staff nicknamed it Franky, after Frankenstein's monster.
For well over a year, Franky had been flying over the rainforest mapping and monitoring its environment. Fortuitously, the space housing the camera was exactly the right size to fit the mini cooler carrying the antivenom. With a few minor modifications, Franky suddenly had a new job.
There was only one problem: Franky had never flown more than 10 kilometers before, and it needed to go four times the distance.
"We had zero idea that this would work and zero guarantees," said Meier. The team decided to press on. "We might as well go all out."
By making it safely to Pampa Hermoza that day, Franky showed that there's hope for delivery drones to play a role in delivering health care in the Amazon.
"The use of the technology will be crucial in the future to improve access to health services, in particular highly specialized services," said Dr. Leonardo Rojas, former executive director of telemedicine at the Ministry of Health in Peru.
But the plucky little engine that could hadn't finished demonstrating what it was capable of.
A return flight was planned. Franky was supposed to deliver a vial of blood for testing back at the hospital in Contamana. Meier and his colleagues swapped in a fresh battery for the return journey.
It was getting late. There were no records of any cargo drones being flown successfully at night over the Amazon. It didn't deter Meier and his team. "We figured we might as well go for gold here," he said.
They strapped a bike light to Franky's nose with yet more gaffer tape.
Just as the team was ready to launch, it realized Franky wasn't connecting to the base station back in Contamana, through which its flight path was programmed. A debate ensued. There was a small chance that if the drone got enough altitude it would manage to connect, said Juan Bergelund, Meier's counterpart back in Contamana.
Meier wasn't so sure.
Franky takes a tumble.
"Even the other Peruvians were saying, 'Are you kidding me?'" said Meier. "We're going to lose the drone, we'll never recover it."
But Bergelund made the call and Franky flew into the darkness.
"All we see is this blinking drone fly off through the night." said Meier. "At this point it was beyond surreal, we were asking for trouble."
Bergelund's bet paid off, and Franky connected to the base station. But due to a slight miscalculation of the GPS coordinates, the drone ended up in a fight with a coconut tree near the field in Contamana.
If such an entanglement had occurred when testing the original $40,000 drone, it could have cost thousands of dollars to repair the damage, Meier said. For Franky, it meant -- yep -- another gaffer tape job and a $3 replacement part. The vial of blood stashed inside was unharmed.
Franky's success provided the whole team with a much-needed reality check on the approach it was taking to cargo drones.
"This awesome, humble Peruvian team had pulled off with just a few thousand dollars in a few hours what a major company had failed to pull off after a few months of planning with a drone that cost more than 10 times that price," Meier said
The Peru Flying Labs team saved the day with Franky the mapping drone.
The report on the field tests, published Monday, concludes that for the price of the original $40,000 drone, WeRobotics could buy 11 E384 Franky-style drones, establishing a whole delivery network. Neither the report, nor Meier, would disclose the US startup that built the original drone.
But two successful flights are not enough on their own to justify building such a network. The team is out in Contamana conducting further tests, this time using E384 UAVs from the get-go. Presuming they are successful, they will conduct further tests in May that will see them push the range up to 100km.
Beyond the Amazon test, WeRobotics is exploring fighting Zika by using its drones to release millions of sterilized, male mosquitoes into an environment where they will compete with local populations to mate with females, reducing the numbers of insects in the subsequent generation.
WeRobotics will have to use larger drones, but it has learned its lesson about the kind of technology it employs.
"It doesn't have to be sexy, it doesn't have to cost $40,000," Meier said. "As long as it works, that's good enough."
Life, disrupted: In Europe, millions of refugees are still searching for a safe place to settle. Tech should be part of the solution. But is it?
Tech Enabled: CNET chronicles tech's role in providing new kinds of accessibility.
Read more:
This medicine-toting drone flew where no one thought it could - CNET
- Yes, But. The Annotated Atlantic. - November 7th, 2009 [November 7th, 2009]
- Health Insurance Benefit Costs by Region - November 8th, 2009 [November 8th, 2009]
- For an Operator, Please Press... - November 8th, 2009 [November 8th, 2009]
- Pollyanna With a Pen: Maine Governor Signs 18 New Health Care Bills into Law - November 8th, 2009 [November 8th, 2009]
- AMA Sounds the Alarm, Medicare Making Yet Another Attempt to Cut Reimbursement - November 8th, 2009 [November 8th, 2009]
- Mass Governor Asks Blue Cross to Keep Higher Employer Contribution - November 8th, 2009 [November 8th, 2009]
- Lifespan and Care New England Plan Monopoly (Again) - November 8th, 2009 [November 8th, 2009]
- Dirigo Health: Con Artists, Liars, and Thieves? - November 8th, 2009 [November 8th, 2009]
- New Orleans: Health Challenges - November 8th, 2009 [November 8th, 2009]
- August a Flurry of Activity - November 8th, 2009 [November 8th, 2009]
- Maine's Dirigo Health Savings One-Third of Original Estimate - November 8th, 2009 [November 8th, 2009]
- “Methodolatry”: My new favorite term for one of the shortcomings of evidence-based medicine - November 8th, 2009 [November 8th, 2009]
- Suzanne Somers’ Knockout: Dangerous misinformation about cancer (part 1) - November 8th, 2009 [November 8th, 2009]
- A science-based blog about GMO - November 8th, 2009 [November 8th, 2009]
- A Not-So-Split Decision - November 8th, 2009 [November 8th, 2009]
- Military Medicine in Iraq - November 8th, 2009 [November 8th, 2009]
- The effective wordsmithing of Amy Wallace - November 8th, 2009 [November 8th, 2009]
- A Science Lesson from a Homeopath and Behavioral Optometrist - November 8th, 2009 [November 8th, 2009]
- Join CFI in opposing funding mandates for quackery in health care reform - November 8th, 2009 [November 8th, 2009]
- Mainstreaming Science-Based Medicine: A Novel Approach - November 8th, 2009 [November 8th, 2009]
- Those who live in glass houses… - November 8th, 2009 [November 8th, 2009]
- J.B. Handley of the anti-vaccine group Generation Rescue: Misogynistic attacks on journalists who champion science - November 8th, 2009 [November 8th, 2009]
- When homeopaths attack medicine and physics - November 8th, 2009 [November 8th, 2009]
- The cancer screening kerfuffle erupts again: “Rethinking” screening for breast and prostate cancer - November 8th, 2009 [November 8th, 2009]
- All Medicines Are Poison! - November 8th, 2009 [November 8th, 2009]
- When Loud Wins: Will Your Tax Dollars Pay For Prayer? - November 8th, 2009 [November 8th, 2009]
- It’s All in Your Head - November 8th, 2009 [November 8th, 2009]
- The Skeptical O.B. joins the Science-Based Medicine crew - November 8th, 2009 [November 8th, 2009]
- The Tragic Death Toll of Homebirth - November 8th, 2009 [November 8th, 2009]
- What’s the right C-section rate? Higher than you think. - November 8th, 2009 [November 8th, 2009]
- Recombinant Human Antithrombin – Milking Nanny Goats for Big Bucks - December 13th, 2009 [December 13th, 2009]
- Does C-section increase the rate of neonatal death? - December 13th, 2009 [December 13th, 2009]
- Man in Coma 23 Years – Is He Really Conscious? - December 13th, 2009 [December 13th, 2009]
- Why Universal Hepatitis B Vaccination Isn’t Quite Universal - December 13th, 2009 [December 13th, 2009]
- Ontario naturopathic prescribing proposal is bad medicine - December 13th, 2009 [December 13th, 2009]
- Naturopaths and the anti-vaccine movement: Hijacking the law in service of pseudoscience - December 13th, 2009 [December 13th, 2009]
- The Institute for Science in Medicine enters the health care reform fray - December 13th, 2009 [December 13th, 2009]
- Neti pots – Ancient Ayurvedic Treatment Validated by Scientific Evidence - December 13th, 2009 [December 13th, 2009]
- Early Intervention for Autism - December 13th, 2009 [December 13th, 2009]
- A temporary reprieve from legislative madness - December 13th, 2009 [December 13th, 2009]
- A critique of the leading study of American homebirth - December 13th, 2009 [December 13th, 2009]
- Lose those holiday pounds - December 13th, 2009 [December 13th, 2009]
- Endocrine disruptors—the one true cause? - December 13th, 2009 [December 13th, 2009]
- Acupuncture for Chronic Prostatitis/Chronic Pelvic Pain Syndrome - December 13th, 2009 [December 13th, 2009]
- Evidence in Medicine: Experimental Studies - December 13th, 2009 [December 13th, 2009]
- Midwives and the assault on scientific evidence - December 13th, 2009 [December 13th, 2009]
- The Mammogram Post-Mortem - December 13th, 2009 [December 13th, 2009]
- An Influenza Recap: The End of the Second Wave - December 13th, 2009 [December 13th, 2009]
- The End of Chiropractic - December 13th, 2009 [December 13th, 2009]
- Cell phones and cancer again, or: Oh, no! My cell phone’s going to give me cancer! (revisited) - December 20th, 2009 [December 20th, 2009]
- Another wrinkle to the USPSTF mammogram guidelines kerfuffle: What about African-American women? - December 20th, 2009 [December 20th, 2009]
- Acupuncture, the P-Value Fallacy, and Honesty - December 20th, 2009 [December 20th, 2009]
- The One True Cause of All Disease - December 20th, 2009 [December 20th, 2009]
- Communicating with the Locked-In - December 20th, 2009 [December 20th, 2009]
- Are the benefits of breastfeeding oversold? - December 20th, 2009 [December 20th, 2009]
- Measles - December 20th, 2009 [December 20th, 2009]
- Radiation from medical imaging and cancer risk - December 21st, 2009 [December 21st, 2009]
- Multiple Sclerosis and Irrational Exuberance - December 21st, 2009 [December 21st, 2009]
- Medical Fun with Christmas Carols - December 22nd, 2009 [December 22nd, 2009]
- Lithium for ALS – Angioplasty for MS - December 23rd, 2009 [December 23rd, 2009]
- “Toxins”: the new evil humours - December 24th, 2009 [December 24th, 2009]
- 2009’s Top 5 Threats To Science In Medicine - December 24th, 2009 [December 24th, 2009]
- Buteyko Breathing Technique – Nothing to Hyperventilate About - December 26th, 2009 [December 26th, 2009]
- The Graston Technique – Inducing Microtrauma with Instruments - December 29th, 2009 [December 29th, 2009]
- The “pharma shill” gambit - December 29th, 2009 [December 29th, 2009]
- Ginkgo biloba – No Effect - December 30th, 2009 [December 30th, 2009]
- Oppose “Big Floss”; practice alternative dentistry - January 1st, 2010 [January 1st, 2010]
- Causation and Hill’s Criteria - January 3rd, 2010 [January 3rd, 2010]
- The life cycle of translational research - January 10th, 2010 [January 10th, 2010]
- The anti-vaccine movement strikes back against Dr. Paul Offit - January 10th, 2010 [January 10th, 2010]
- Osteoporosis Drugs: Good Medicine or Big Pharma Scam? - January 10th, 2010 [January 10th, 2010]
- Acupuncture for Hot Flashes - January 10th, 2010 [January 10th, 2010]
- The case for neonatal circumcision - January 10th, 2010 [January 10th, 2010]
- A victory for science-based medicine - January 10th, 2010 [January 10th, 2010]
- James Ray and testosterone replacement therapy (TRT) - January 10th, 2010 [January 10th, 2010]
- The Water Cure: Another Example of Self Deception and the “Lone Genius” - January 12th, 2010 [January 12th, 2010]
- Be careful what you wish for, Dr. Dossey, you just might get it - January 13th, 2010 [January 13th, 2010]
- You. You. Who are you calling a You You? - January 15th, 2010 [January 15th, 2010]
- The War on Salt - January 16th, 2010 [January 16th, 2010]
- Is breech vaginal delivery safe? - January 16th, 2010 [January 16th, 2010]